Clinical

Videos

“New things are being developed and, I believe, at the moment showing great initiative and resolve,” says Justin Chee, MD.

Dr. Chee on novel Optilume device for patients with recurrent anterior urethral stricture

“I think it's important for people to recognize this revolution that's going on, to see that we're going from what fell to why it fell,” says John O. L. DeLancey, MD.

Dr. Delancey on improving success rates in pelvic floor surgery 

Articles

The RENOVA iStim tibial neuromodulation system is a wireless peripheral neurostimulator device that a clinician implants in the patient’s ankle with the patient under local anesthesia. 

Pivotal trial of neuromodulation device for urge urinary incontinence completes enrollment

“Men do well and they don't have a really high risk of outcomes that we don't want them to have and that patients don't want to have, which is really the need to catheterize,” says David A. Ginsberg, MD.

Dr. Ginsberg urges clinicians to consider onabotulinumtoxinA for OAB and urinary incontinence

"The majority of patients who get onabotulinumtoxinA (Botox) don't need to use a catheter at all," says David A. Ginsberg, MD.

Expert highlights long-term safety with Botox for bladder disorders

In a recent study, Michael A. Weber, MD, and co-authors assessed the blood pressure and heart rate profiles of the beta 3 adrenergic receptor agonist vibegron in treating patients with OAB. 

Study finds vibegron has no adverse ambulatory effects in patients with OAB

"We're moving from an era where it was all based on judgment, and experience, to an era where treatments will be based on firm evidence of the structural failures present in each patient," says John O. L. DeLancey, MD.

What is the future of pelvic floor surgery?

“What our studies were looking at was a novel device that could potentially help bridge the gap between [endoscopic treatment and urethroplasty] to achieve endoscopic treatment and achieve greater success,” says Justin Chee, MD.

Expert discusses studies of Optilume drug-coated balloon for urethral strictures

The FDA previously approved the Ieva Digital Therapeutic System for the treatment of urinary incontinence and pelvic floor strengthening in women.

FDA grants breakthrough device designation to leva system for chronic fecal incontinence

“Doing this study allows us to say, 'With repeat treatments, we're not seeing a greater risk of retention, and we're not seeing a greater risk of UTI,'" says David A. Ginsberg, MD.

OAB and Incontinence